MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 4.55 HKD 1.11% Market Closed
Market Cap: 1.9B HKD
Have any thoughts about
MicroTech Medical Hangzhou Co Ltd?
Write Note

MicroTech Medical Hangzhou Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MicroTech Medical Hangzhou Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Accrued Liabilities
ÂĄ34.9m
CAGR 3-Years
42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accrued Liabilities
ÂĄ132.8m
CAGR 3-Years
41%
CAGR 5-Years
42%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accrued Liabilities
ÂĄ321.1m
CAGR 3-Years
38%
CAGR 5-Years
42%
CAGR 10-Years
49%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accrued Liabilities
ÂĄ3.9B
CAGR 3-Years
24%
CAGR 5-Years
23%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Accrued Liabilities
ÂĄ116.9m
CAGR 3-Years
55%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accrued Liabilities
ÂĄ879.6m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
1.9B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
5.84 HKD
Undervaluation 22%
Intrinsic Value
Price

See Also

What is MicroTech Medical Hangzhou Co Ltd's Accrued Liabilities?
Accrued Liabilities
34.9m CNY

Based on the financial report for Dec 31, 2023, MicroTech Medical Hangzhou Co Ltd's Accrued Liabilities amounts to 34.9m CNY.

What is MicroTech Medical Hangzhou Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
42%

Over the last year, the Accrued Liabilities growth was -12%. The average annual Accrued Liabilities growth rates for MicroTech Medical Hangzhou Co Ltd have been 42% over the past three years .

Back to Top